Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Phase II w/wo nivolumab in first- or second-line metastatic triple-negative breast cancer

Protocol: OSU-17384

Full Title

A randomized phase II trial of carboplatin with or without nivolumab in first- or second-line metastatic triple-negative breast cancer

Breast Cancer